To investigate the role of MSI2 in NSCLC development, we compared the tumorigenesis in mice with lung-specific <i>Kras</i>-activating mutation and <i>Trp53</i> deletion, with and without <i>Msi2</i> deletion (KPM2 versus KP mice). This evidence concerns the gene KRAS and non-small cell lung carcinoma.